Related Experiment Video
Updated: Apr 18, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
Published on: April 28, 2023
Is it necessary to re-evaluate diagnostic criteria for Wilson disease in children?
Oya Balcı Sezer1, Peren Perk, Ferda Özbay Hoşnut
1Department of Pediatric Gastroenterology, Başkent University Faculty of Medicine, Ankara, Turkey. oyabalci@yahoo.com.
Insights
Diagnosing Wilson Disease (WD) in children is difficult. This study establishes new liver and urine copper cut-off values to better differentiate WD from other pediatric liver diseases.
Area of Science:
- Pediatric Hepatology
- Medical Diagnostics
- Trace Element Metabolism
Background:
- Wilson Disease (WD) diagnosis in children is challenging due to overlapping symptoms with other chronic liver diseases.
- Elevated liver copper levels can occur in conditions beyond WD, complicating differential diagnosis.
- Accurate diagnostic markers are crucial for timely WD treatment in pediatric populations.
Purpose of the Study:
- To establish specific liver and 24-hour urinary copper cut-off values for differentiating Wilson Disease (WD) in children.
- To compare these novel cut-off values against existing diagnostic criteria.
- To improve the diagnostic accuracy of WD in pediatric patients with chronic liver disease.
Main Methods:
- Analyzed data from 76 pediatric patients (35 WD, 41 non-WD).
- Measured liver and 24-hour urinary copper levels using atomic absorption spectrometry.
- Employed Receiver Operating Characteristic (ROC) analysis to determine optimal diagnostic cut-off values.
Main Results:
- A liver copper cut-off of 98 µg/g showed 91% sensitivity and 65.4% specificity for WD.
- A 24-hour urinary copper cut-off of 67.5 µg/24h demonstrated 85% sensitivity and 71% specificity for WD.
- Both cut-offs provided significant diagnostic capability (AUC > 0.83).
Conclusions:
- Established liver and urinary copper cut-off values differ from current diagnostic standards for pediatric WD.
- The findings suggest a need for revised diagnostic thresholds for WD in children.
- Further large-scale studies are recommended to validate these pediatric-specific copper cut-offs.
Background/Aims:
The differential diagnosis of Wilson Disease (WD) is challenging, especially in children, because liver copper levels may also increase in other chronic liver diseases with bile stasis. The aim of this study is to determine urine and liver copper cut-off values to differentiate WD from other chronic liver diseases (non-WD, NWD) in children.
Materials And Methods:
Seventy-six patients participated in the study, 35 with WD and 41 with NWD. The two groups were divided into two subgroups according to the presence of cholestasis. At the time of diagnosis, age, sex, biochemical test results, serum ceruloplasmin, baseline 24-h urinary copper levels, liver biopsy histological findings, liver copper levels, and Child-Pugh scores were obtained from medical records. Copper content in liver tissue and copper levels in urine were measured by atomic absorption spectrometry. Cut-off values for differentiation of WD from NWD were determined by receiver operating characteristic (ROC) analysis.
Results:
A liver copper cut-off value of 98 µg/g indicated WD with 91% sensitivity and 65.4% specificity (area under the curve =0.838, 95% CI: 0.749-0.927). A 24-h urinary copper cut-off value of 67.5 µg/24h indicated WD with 85% sensitivity and 71% specificity (area under the curve =0.843, 95% CI: 0.752-0.934).
Conclusion:
In this study of pediatric chronic liver disease patients, copper cut-off values for distinguishing WD differed substantially from those used for diagnosis. A larger scale study is warranted to re-evaluate liver copper and 24-h urinary copper cut-offs for children with suspected WD.
More Related Videos
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Nephrotic Syndrome II : Assessment and Medical Management
Lysosomal Hydrolases
Inborn Errors of Metabolism
Diabetes Insipidus I: Introduction
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis